sarpogrelate has been researched along with Chronic Kidney Diseases in 3 studies
sarpogrelate: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sarpogrelate treatment repressed the HFD/STZ-induced CD31 and vascular endothelial growth factor receptor-2 expressions, indicating the attenuation of glomerular endothelial proliferation." | 1.43 | Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice. ( Choi, BH; Kim, DH; Ku, SK; Kwak, MK; Oh, E; Park, JH, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, J | 1 |
| Pei, Z | 1 |
| Yu, M | 1 |
| Li, X | 1 |
| Wang, L | 1 |
| Lin, Y | 1 |
| Chen, X | 1 |
| Liu, X | 1 |
| Lee, SA | 1 |
| Suh, JW | 1 |
| Park, JJ | 1 |
| Yoon, CH | 1 |
| Cho, YS | 1 |
| Youn, TJ | 1 |
| Chae, IH | 1 |
| Kim, HS | 1 |
| Kim, SH | 1 |
| Choi, DJ | 1 |
| Kim, DH | 1 |
| Choi, BH | 1 |
| Ku, SK | 1 |
| Park, JH | 1 |
| Oh, E | 1 |
| Kwak, MK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multicenter Randomized Trial Evaluating the Efficacy of Sarpogrelate on Ischemic Heart Disease After Drug-eluting Stent Implantation in Patients With Diabetes Mellitus or Renal Impairment[NCT02294643] | Phase 3 | 220 participants (Actual) | Interventional | 2009-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for sarpogrelate and Chronic Kidney Diseases
| Article | Year |
|---|---|
Study design of the influence of SErotonin inhibition on patients with RENAl impairment or diabetes undergoing drug-eluting stent implantation (SERENADE) study: A multicenter, open-label, prospective, randomized study.
Topics: Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosis; Diabetes Mellitus; Drug Therapy, Co | 2015 |
2 other studies available for sarpogrelate and Chronic Kidney Diseases
| Article | Year |
|---|---|
Combinational Use of Antiplatelet Medication Sarpogrelate with Therapeutic Drug Rosuvastatin in Treating High-Cholesterol Diet-Induced Chronic Kidney Disease in ApoE-Deficient Mice.
Topics: Animals; Apolipoproteins E; Cholesterol, Dietary; Diet, High-Fat; Drug Therapy, Combination; Gene Ex | 2020 |
Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice.
Topics: Animals; Cell Proliferation; Diet, High-Fat; Dose-Response Relationship, Drug; Endothelial Cells; Fi | 2016 |